scispace - formally typeset
R

Ronald M. Evans

Researcher at Salk Institute for Biological Studies

Publications -  729
Citations -  176865

Ronald M. Evans is an academic researcher from Salk Institute for Biological Studies. The author has contributed to research in topics: Nuclear receptor & Receptor. The author has an hindex of 199, co-authored 708 publications receiving 166722 citations. Previous affiliations of Ronald M. Evans include Scripps Research Institute & University of California, Davis.

Papers
More filters
Proceedings ArticleDOI

Abstract 396: The bile acid receptor FXR suppress colitis-induced colon cancer

TL;DR: The role of FXR is highlighted in inflammation induced colon cancer, opening new therapeutic avenues for the treatment of CAC and the role of crypt-villus architecture in establishing a BA gradient necessary for homeostasis is shown.
Patent

Compositions and methods for treating age-related diabetes and related disorders

TL;DR: In this article, an anti-ST2 antibody was used to decrease age-related fTreg accumulation and restore insulin sensitivity, thereby treating agerelated insulin resistance, type 2 diabetes and related disorders.
Journal ArticleDOI

Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity.

TL;DR: In this article , a synthetic estrogen receptor-related receptor (ERRα) pan agonist, SLU-PP-332, was used to increase the type IIa oxidative skeletal muscle fibers and enhanced exercise endurance.
Journal ArticleDOI

Reply to "PPAR-γ regulates pharmacological but not physiological or pathological osteoclast formation".

TL;DR: PPAR-γ regulates pharmacological but not physiological or pathological osteoclast formation and may have an important role in wound healing and wound healing-like properties.